Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Non-Current Deferred Tax Liability (2016 - 2021)

Tenax Therapeutics' Non-Current Deferred Tax Liability history spans 2 years, with the latest figure at $8.0 million for Q3 2016.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed N/A to $8.0 million in Q3 2016 year-over-year; TTM through Sep 2016 was $8.0 million, a N/A change, with the full-year FY2015 number at $8.0 million, changed N/A from a year prior.
  • Non-Current Deferred Tax Liability hit $8.0 million in Q3 2016 for Tenax Therapeutics, roughly flat from $8.0 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for TENX hit a ceiling of $8.0 million in Q4 2015 and a floor of $8.0 million in Q4 2015.